By Benjamin Chiou
Date: Monday 12 Jan 2026
(Sharecast News) - Shares in Nasdaq-listed Abivax soared in pre-market trading on Monday after reports emerged that pharma giant Eli Lilly was preparing a $17.5bn bid for the Paris-based biotech firm.
| Currency | US Dollars |
| Share Price | $ 1,064.29 |
| Change Today | $ -23.09 |
| % Change | -2.12 % |
| 52 Week High | $1,109.94 |
| 52 Week Low | $625.65 |
| Volume | 2,592,850 |
| Shares Issued | 948.17m |
| Market Cap | $1,009,128m |
| Beta | 0.02 |
| RiskGrade | 179 |
| Strong Buy | 12 |
| Buy | 12 |
| Neutral | 7 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 31 |

| Time | Volume / Share Price |
| 15:59 | 40 @ $1,064.41 |
| 15:59 | 270 @ $1,064.41 |
| 15:59 | 40 @ $1,064.41 |
| 15:59 | 40 @ $1,064.41 |
| 15:59 | 49 @ $1,064.41 |
You are here: research